When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LPTX - Leap anti-DKK1 antibody an Orphan Drug in U.S. for gastric cancer
Leap Therapeutics Inc.
The FDA has designated Leap Therapeutics' (NASDAQ:LPTX) Phase 1/2-stage DKN-01, a humanized monoclonal antibody that blocks the activity of the Dickkopt-1 (DKK1) protein, an Orphan Drug for the treatment of gastric and gastroesophageal junction cancer.
More news on: Leap Therapeutics, Inc., Healthcare stocks news, Stocks on the move,